Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.
Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may suffer from this complication. CDA is a complex trait with a polygenic component that is mainly unidentified. We propose that levels of intermediate molecular phenotypes (IMPs) in the myocardium associa...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2023 |
| País: | España |
| Institución: | Instituto de Salud Carlos III (ISCIII) |
| Repositorio: | Repisalud |
| Idioma: | inglés |
| OAI Identifier: | oai:repisalud.isciii.es:20.500.12105/16571 |
| Acceso en línea: | http://hdl.handle.net/20.500.12105/16571 |
| Access Level: | acceso abierto |
| Palabra clave: | Cardiotoxicity Neoplasms Female Animals Mice Anthracyclines Genetic Markers Antibiotics, Antineoplastic Phenotype |
| id |
ES_0e5ff309d1ab2f64b6069879a53d8de4 |
|---|---|
| oai_identifier_str |
oai:repisalud.isciii.es:20.500.12105/16571 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.Gómez-Vecino, AuroraCorchado-Cobos, RobertoBlanco-Gómez, AdriánGarcía-Sancha, NataliaCastillo-Lluva, SoniaMartín-García, AnaMendiburu-Eliçabe, MarinaPrieto, CarlosRuiz-Pinto, SaraPita, GuillermoVelasco-Ruiz, AlejandroPatino-Alonso, CarmenGalindo-Villardón, PurificaciónVera-Pedrosa, María LinarejosJalife, JoseMao, Jian-HuaMacías de Plasencia, GuillermoCastellanos-Martín, AndrésSáez-Freire, María Del MarFraile-Martín, SusanaRodrigues-Teixeira, TelmoGarcía-Macías, CarmenGalvis-Jiménez, Julie MilenaGarcía-Sánchez, AsunciónIsidoro-García, MaríaFuentes, ManuelGarcía-Cenador, María BegoñaGarcía-Criado, Francisco JavierGarcía-Hernández, Juan LuisHernández-García, María ÁngelesCruz-Hernández, Juan JesúsRodríguez-Sánchez, César AugustoGarcía-Sancho, Alejandro MartínPérez-López, EstefaníaPérez-Martínez, AntonioGutiérrez-Larraya, FedericoCartón, Antonio JGarcía-Sáenz, José ÁngelPatiño-García, AnaMartín, MiguelAlonso-Gordoa, TeresaVulsteke, ChristofCroes, LieselotHatse, SigridVan Brussel, ThomasLambrechts, DietherWildiers, HansChang, HangHolgado-Madruga, MarinaGonzález-Neira, AnnaSánchez, Pedro LPérez Losada, JesúsCardiotoxicityNeoplasmsFemaleAnimalsMiceAnthracyclinesGenetic MarkersAntibiotics, AntineoplasticPhenotypeCardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may suffer from this complication. CDA is a complex trait with a polygenic component that is mainly unidentified. We propose that levels of intermediate molecular phenotypes (IMPs) in the myocardium associated with histopathological damage could explain CDA susceptibility, so variants of genes encoding these IMPs could identify patients susceptible to this complication. Thus, a genetically heterogeneous cohort of mice (n = 165) generated by backcrossing were treated with doxorubicin and docetaxel. We quantified heart fibrosis using an Ariol slide scanner and intramyocardial levels of IMPs using multiplex bead arrays and QPCR. We identified quantitative trait loci linked to IMPs (ipQTLs) and cdaQTLs via linkage analysis. In three cancer patient cohorts, CDA was quantified using echocardiography or Cardiac Magnetic Resonance. CDA behaves as a complex trait in the mouse cohort. IMP levels in the myocardium were associated with CDA. ipQTLs integrated into genetic models with cdaQTLs account for more CDA phenotypic variation than that explained by cda-QTLs alone. Allelic forms of genes encoding IMPs associated with CDA in mice, including AKT1, MAPK14, MAPK8, STAT3, CAS3, and TP53, are genetic determinants of CDA in patients. Two genetic risk scores for pediatric patients (n = 71) and women with breast cancer (n = 420) were generated using machine-learning Least Absolute Shrinkage and Selection Operator (LASSO) regression. Thus, IMPs associated with heart damage identify genetic markers of CDA risk, thereby allowing more personalized patient management.Multidisciplinary Digital Publishing Institute (MDPI)Instituto de Salud Carlos IIIUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)Ministerio de Ciencia y Competitividad (España)Ministerio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)Fundación La Caixa20232023-10-1720232023-07-2720232023-07-27journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/20.500.12105/16571reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Atribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/165712026-06-12T12:43:37Z |
| dc.title.none.fl_str_mv |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. |
| title |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. |
| spellingShingle |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. Gómez-Vecino, Aurora Cardiotoxicity Neoplasms Female Animals Mice Anthracyclines Genetic Markers Antibiotics, Antineoplastic Phenotype |
| title_short |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. |
| title_full |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. |
| title_fullStr |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. |
| title_full_unstemmed |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. |
| title_sort |
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. |
| dc.creator.none.fl_str_mv |
Gómez-Vecino, Aurora Corchado-Cobos, Roberto Blanco-Gómez, Adrián García-Sancha, Natalia Castillo-Lluva, Sonia Martín-García, Ana Mendiburu-Eliçabe, Marina Prieto, Carlos Ruiz-Pinto, Sara Pita, Guillermo Velasco-Ruiz, Alejandro Patino-Alonso, Carmen Galindo-Villardón, Purificación Vera-Pedrosa, María Linarejos Jalife, Jose Mao, Jian-Hua Macías de Plasencia, Guillermo Castellanos-Martín, Andrés Sáez-Freire, María Del Mar Fraile-Martín, Susana Rodrigues-Teixeira, Telmo García-Macías, Carmen Galvis-Jiménez, Julie Milena García-Sánchez, Asunción Isidoro-García, María Fuentes, Manuel García-Cenador, María Begoña García-Criado, Francisco Javier García-Hernández, Juan Luis Hernández-García, María Ángeles Cruz-Hernández, Juan Jesús Rodríguez-Sánchez, César Augusto García-Sancho, Alejandro Martín Pérez-López, Estefanía Pérez-Martínez, Antonio Gutiérrez-Larraya, Federico Cartón, Antonio J García-Sáenz, José Ángel Patiño-García, Ana Martín, Miguel Alonso-Gordoa, Teresa Vulsteke, Christof Croes, Lieselot Hatse, Sigrid Van Brussel, Thomas Lambrechts, Diether Wildiers, Hans Chang, Hang Holgado-Madruga, Marina González-Neira, Anna Sánchez, Pedro L Pérez Losada, Jesús |
| author |
Gómez-Vecino, Aurora |
| author_facet |
Gómez-Vecino, Aurora Corchado-Cobos, Roberto Blanco-Gómez, Adrián García-Sancha, Natalia Castillo-Lluva, Sonia Martín-García, Ana Mendiburu-Eliçabe, Marina Prieto, Carlos Ruiz-Pinto, Sara Pita, Guillermo Velasco-Ruiz, Alejandro Patino-Alonso, Carmen Galindo-Villardón, Purificación Vera-Pedrosa, María Linarejos Jalife, Jose Mao, Jian-Hua Macías de Plasencia, Guillermo Castellanos-Martín, Andrés Sáez-Freire, María Del Mar Fraile-Martín, Susana Rodrigues-Teixeira, Telmo García-Macías, Carmen Galvis-Jiménez, Julie Milena García-Sánchez, Asunción Isidoro-García, María Fuentes, Manuel García-Cenador, María Begoña García-Criado, Francisco Javier García-Hernández, Juan Luis Hernández-García, María Ángeles Cruz-Hernández, Juan Jesús Rodríguez-Sánchez, César Augusto García-Sancho, Alejandro Martín Pérez-López, Estefanía Pérez-Martínez, Antonio Gutiérrez-Larraya, Federico Cartón, Antonio J García-Sáenz, José Ángel Patiño-García, Ana Martín, Miguel Alonso-Gordoa, Teresa Vulsteke, Christof Croes, Lieselot Hatse, Sigrid Van Brussel, Thomas Lambrechts, Diether Wildiers, Hans Chang, Hang Holgado-Madruga, Marina González-Neira, Anna Sánchez, Pedro L Pérez Losada, Jesús |
| author_role |
author |
| author2 |
Corchado-Cobos, Roberto Blanco-Gómez, Adrián García-Sancha, Natalia Castillo-Lluva, Sonia Martín-García, Ana Mendiburu-Eliçabe, Marina Prieto, Carlos Ruiz-Pinto, Sara Pita, Guillermo Velasco-Ruiz, Alejandro Patino-Alonso, Carmen Galindo-Villardón, Purificación Vera-Pedrosa, María Linarejos Jalife, Jose Mao, Jian-Hua Macías de Plasencia, Guillermo Castellanos-Martín, Andrés Sáez-Freire, María Del Mar Fraile-Martín, Susana Rodrigues-Teixeira, Telmo García-Macías, Carmen Galvis-Jiménez, Julie Milena García-Sánchez, Asunción Isidoro-García, María Fuentes, Manuel García-Cenador, María Begoña García-Criado, Francisco Javier García-Hernández, Juan Luis Hernández-García, María Ángeles Cruz-Hernández, Juan Jesús Rodríguez-Sánchez, César Augusto García-Sancho, Alejandro Martín Pérez-López, Estefanía Pérez-Martínez, Antonio Gutiérrez-Larraya, Federico Cartón, Antonio J García-Sáenz, José Ángel Patiño-García, Ana Martín, Miguel Alonso-Gordoa, Teresa Vulsteke, Christof Croes, Lieselot Hatse, Sigrid Van Brussel, Thomas Lambrechts, Diether Wildiers, Hans Chang, Hang Holgado-Madruga, Marina González-Neira, Anna Sánchez, Pedro L Pérez Losada, Jesús |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Instituto de Salud Carlos III Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) Ministerio de Ciencia y Competitividad (España) Ministerio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) Fundación La Caixa |
| dc.subject.none.fl_str_mv |
Cardiotoxicity Neoplasms Female Animals Mice Anthracyclines Genetic Markers Antibiotics, Antineoplastic Phenotype |
| topic |
Cardiotoxicity Neoplasms Female Animals Mice Anthracyclines Genetic Markers Antibiotics, Antineoplastic Phenotype |
| description |
Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may suffer from this complication. CDA is a complex trait with a polygenic component that is mainly unidentified. We propose that levels of intermediate molecular phenotypes (IMPs) in the myocardium associated with histopathological damage could explain CDA susceptibility, so variants of genes encoding these IMPs could identify patients susceptible to this complication. Thus, a genetically heterogeneous cohort of mice (n = 165) generated by backcrossing were treated with doxorubicin and docetaxel. We quantified heart fibrosis using an Ariol slide scanner and intramyocardial levels of IMPs using multiplex bead arrays and QPCR. We identified quantitative trait loci linked to IMPs (ipQTLs) and cdaQTLs via linkage analysis. In three cancer patient cohorts, CDA was quantified using echocardiography or Cardiac Magnetic Resonance. CDA behaves as a complex trait in the mouse cohort. IMP levels in the myocardium were associated with CDA. ipQTLs integrated into genetic models with cdaQTLs account for more CDA phenotypic variation than that explained by cda-QTLs alone. Allelic forms of genes encoding IMPs associated with CDA in mice, including AKT1, MAPK14, MAPK8, STAT3, CAS3, and TP53, are genetic determinants of CDA in patients. Two genetic risk scores for pediatric patients (n = 71) and women with breast cancer (n = 420) were generated using machine-learning Least Absolute Shrinkage and Selection Operator (LASSO) regression. Thus, IMPs associated with heart damage identify genetic markers of CDA risk, thereby allowing more personalized patient management. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2023 2023-10-17 2023 2023-07-27 2023 2023-07-27 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12105/16571 |
| url |
http://hdl.handle.net/20.500.12105/16571 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 4.0 Internacional http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 4.0 Internacional http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
| publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
| dc.source.none.fl_str_mv |
reponame:Repisalud instname:Instituto de Salud Carlos III (ISCIII) |
| instname_str |
Instituto de Salud Carlos III (ISCIII) |
| reponame_str |
Repisalud |
| collection |
Repisalud |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869403393501429761 |
| score |
15.812429 |